|
|
|
|
| LEADER |
01777nam a2200361 u 4500 |
| 001 |
EB000944111 |
| 003 |
EBX01000000000000000737701 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 020 |
|
|
|a 0309118662
|
| 020 |
|
|
|a 9780309118668
|
| 050 |
|
4 |
|a RA644.I6
|
| 245 |
0 |
0 |
|a Antivirals for pandemic influenza
|h Elektronische Ressource
|b guidance on developing a distribution and dispensing program
|c Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies
|
| 260 |
|
|
|a Washington, DC
|b National Academies Press
|c 2008, c2008
|
| 300 |
|
|
|a x, 122 p.
|c 23 cm
|
| 505 |
0 |
|
|a Introduction -- Antiviral effectiveness, safety, and supply -- Ethics, decision making, and communication -- Who should get antivirals and where?
|
| 505 |
0 |
|
|a Includes bibliographical references: p. 87-92
|
| 653 |
|
|
|a United States
|
| 653 |
|
|
|a Antiviral Agents
|
| 653 |
|
|
|a Disease Outbreaks / prevention & control
|
| 653 |
|
|
|a Influenza, Human / epidemiology
|
| 653 |
|
|
|a Influenza Vaccines
|
| 653 |
|
|
|a Influenza, Human / prevention & control
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.)
|b Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.)
|b Board on Population Health and Public Health Practice
|
| 710 |
2 |
|
|a United States
|b Department of Health and Human Services
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK214504
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 614.518
|
| 082 |
0 |
|
|a 140
|
| 082 |
0 |
|
|a 610
|